Yi-Chiang Hsu Selected Research

Yi-Chiang Hsu Research Topics

Disease

35	Neoplasms (Cancer) 11/2023 - 10/2007
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2017 - 03/2012
6	Breast Neoplasms (Breast Cancer) 03/2023 - 09/2012
5	Glioma (Gliomas) 04/2023 - 01/2012
5	Nasopharyngeal Carcinoma 12/2018 - 05/2009
4	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 10/2007
4	Keloid 12/2010 - 06/2006
3	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 10/2010
3	Adenocarcinoma 03/2023 - 09/2012
3	Squamous Cell Carcinoma of Head and Neck 12/2022 - 08/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 06/2013
2	Body Weight (Weight, Body) 10/2022 - 03/2007
2	Neoplasm Metastasis (Metastasis) 03/2017 - 12/2016
2	Carcinoma (Carcinomatosis) 06/2016 - 05/2009
2	Infections 06/2012 - 03/2012
2	Carcinogenesis 06/2012 - 03/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Osteoporosis 08/2021
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Necrosis 01/2018
1	Melanoma (Melanoma, Malignant) 03/2017
1	Burns 01/2015
1	Atrophy 01/2015

Drug/Important Bio-Agent (IBA)

7	sulforaphaneIBA 03/2023 - 01/2012
6	DiarylheptanoidsIBA 09/2012 - 10/2007
5	Cyclin B1IBA 03/2023 - 06/2013
5	Proteins (Proteins, Gene)FDA Link 09/2016 - 03/2007
4	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 06/2015
4	cucurbitacin EIBA 01/2019 - 08/2013
4	AntioxidantsIBA 09/2012 - 10/2007
4	CollagenIBA 03/2007 - 06/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2007 - 06/2006
3	bardoxoloneIBA 04/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 03/2017 - 01/2014
3	isothiocyanic acidIBA 09/2016 - 01/2012
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2013 - 07/2012
3	CurcuminIBA 09/2012 - 10/2007
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2007 - 01/2007
3	Collagen Type I (Type I Collagen)IBA 03/2007 - 06/2006
2	Oleanolic AcidIBA 04/2023 - 02/2023
2	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 01/2018
2	Therapeutic UsesIBA 02/2023 - 12/2010
2	TriterpenesIBA 01/2021 - 01/2017
2	CyclinsIBA 01/2018 - 03/2013
2	Simvastatin (Zocor)FDA LinkGeneric 01/2018 - 03/2013
2	CXC ChemokinesIBA 03/2017 - 12/2016
2	PolymersIBA 12/2016 - 07/2012
2	PolyethyleneimineIBA 12/2016 - 06/2013
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 06/2012 - 03/2012
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 06/2012 - 03/2012
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2007 - 06/2006
2	Tissue Inhibitor of Metalloproteinase-1IBA 03/2007 - 01/2007
1	cucurbitacin IIBA 11/2023
1	Anti-Allergic Agents (Antiallergic Agents)IBA 02/2023
1	1- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- oneIBA 12/2022
1	Nicotinamide PhosphoribosyltransferaseIBA 12/2022
1	Nonsense Codon (Nonsense Mutation)IBA 11/2022
1	Investigational DrugsIBA 11/2022
1	atalurenIBA 11/2022
1	HDL CholesterolIBA 10/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	Blood Glucose (Blood Sugar)IBA 10/2022
1	Protein Isoforms (Isoforms)IBA 06/2022
1	Phosphotransferases (Kinase)IBA 10/2021
1	Small Molecule LibrariesIBA 08/2021
1	(2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oic acid) trifluoroethylamideIBA 01/2021
1	histone deacetylase 3IBA 05/2019
1	thiazolyl blueIBA 05/2019
1	Cyclin D2IBA 05/2019
1	Hormones (Hormone)IBA 12/2018
1	angiotensin I (1-7)IBA 12/2018
1	Cyclin D1IBA 01/2018
1	Annexin A5IBA 01/2018
1	Propidium (Propidium Iodide)IBA 01/2018
1	CholesterolIBA 01/2018
1	Capsaicin (Zostrix)FDA Link 06/2017
1	Matrix Metalloproteinases (MMPs)IBA 03/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2017
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2017
1	graphene oxideIBA 12/2016
1	Small Interfering RNA (siRNA)IBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2016
1	IsothiocyanatesIBA 09/2016
1	Conditioned Culture MediaIBA 06/2016
1	InterferonsIBA 06/2016
1	Cisplatin (Platino)FDA LinkGeneric 02/2016
1	MelatoninIBA 01/2016
1	hepatoma-derived growth factorIBA 11/2014
1	Messenger RNA (mRNA)IBA 11/2014

Therapy/Procedure

6	Therapeutics 12/2022 - 05/2009
5	Drug Therapy (Chemotherapy) 01/2017 - 05/2009
4	Radiotherapy 01/2017 - 05/2009
2	Hysterectomy 01/2017 - 09/2016
2	Chemoprevention 07/2012 - 12/2010
1	Glycemic Control 10/2022
1	Aftercare (After-Treatment) 05/2019
1	Denervation 01/2015